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Abstract
Introduction: Type 4 renal tubular acidosis is an uncommon clinical manifestation of systemic lupus
erythematosus and has been reported to portend a poor prognosis. To the best of our knowledge, this is the first
case report which highlights the successful management of a patient with systemic lupus erythematosus
complicated by type 4 renal tubular acidosis who did not do poorly.
Case presentation: A 44-year-old Hispanic woman developed a non-anion gap hyperkalemic metabolic acidosis
consistent with type 4 renal tubular acidosis while being treated in the hospital for recently diagnosed systemic
lupus erythematosus with multi-organ involvement. She responded well to treatment with corticosteroids,
hydroxychloroquine and mycophenolate mofetil. Normal renal function was achieved prior to discharge and
remained normal at the patient’s one-month follow-up examination.
Conclusion: This case increases awareness of an uncommon association between systemic lupus erythematosus
and type 4 renal tubular acidosis and suggests a positive impact of early diagnosis and appropriate
immunosuppressive treatment on the patient’s outcome.
Introduction
Inability of the kidney either to excrete sufficient net
acid or to retain sufficient bicarbonate results in a group
of disorders known as renal tubular acidoses (RTAs) [1].
These are normal anion gap hyperchloremic acidoses. In
the traditional classification, type 4 is the only variant
associated with hyperkalemia. Compared to the other
d i s t a lR T A s ,i nt y p e4R T A ,t h ec o l l e c t i n gd u c tf a i l st o
excrete both protons and potassium. Such a scenario
arises when there is a quantitative or qualitative aldos-
terone deficiency or a genetic or acquired molecular
defect in the relevant transporters. Aldosterone activity
is necessary for adequate sodium reabsorption by the
epithelial sodium channels. These channels are located
on the luminal surface of principal cells in the terminal
portions of the nephron. Under normal conditions, they
generate a lumen-negative potential, which is essential
for potassium and proton secretion [2].
RTA is a rare complication of systemic lupus erythe-
matosus (SLE) and can pose a diagnostic dilemma [3]. If
inappropriately treated, chronic serum acidity ensues,
predisposing to growth retardation, nephrolithiasis, bone
disease, chronic kidney disease and even end-stage renal
disease. Type 4 RTA is less commonly associated with
SLE than type 1. Patients with type 4 RTA usually have
higher SLE disease activity index (SLEDAI) scores [4].
We report a case of a patient with a high SLEDAI score
and type 4 RTA secondary to SLE who received prompt
and appropriate treatment and did not do poorly.
Case presentation
A 44-year-old Hispanic woman presented to the hospital
with a six-month history of generalized weakness,
weight loss of 40 pounds over a four-month period and
a two-week history of progressively worsening dyspnea.
She had had hypertension for five years for which she
was being treated with lisinopril but had been noncom-
pliant for over three years because of financial con-
straints. The patient denied any alcohol or illicit drug
use and was a lifelong non-smoker.
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her temperature was 37°C, her respiratory rate was
24 breaths/minute, her oxygen saturation level was 92%
on room air and her pulse rate was 88 beats/minute.
A physical examination revealed an ill-looking woman
with mucosal pallor, generalized wasting and non-
tender, rubbery axillary and inguinal lymphadenopathy.
There was no evidence of cyanosis, digital clubbing, pit-
ting edema, skin rash or joint deformities. Her abdomen
was mildly distended but non-tender, with no organo-
megaly detected. Dullness to percussion and decreased
breath sounds over the left base were noted on the
respiratory system examination. The cardiovascular and
neurological examinations were unremarkable.
Initial laboratory investigations (Table 1) revealed ane-
mia, leukopenia, elevated blood urea nitrogen and ele-
vated serum creatinine. Urinalysis showed trace
proteinuria. Chest radiography revealed bilateral pleural
effusions that were determined to be exudative in nature
on the basis of thoracocentesis. There was a high index
of suspicion for malignancy; however, the results of
chest, abdomen and pelvis computed tomography scans
and an axillary lymph node biopsy did not confirm this.
Human immunodeficiency virus and tuberculin skin
tests were negative.
On day four of admission, she developed acute inflam-
matory arthritis of the elbows and knees. A serological
workup revealed high anti-nuclear antibody, anti-dou-
ble-stranded DNA antibody and anti-Smith antibody
titers, with low complement 3 levels. An active sediment
was noted on the basis of urinalysis (Table 2). The
patient’s renal impairment persisted, and her glomerular
filtration rate was estimated to be 53 ml/min/1.73 m
2.
A review of blood results since admission showed evidence
of documented leukopenia on more than two occasions.
On day 5 of admission, the patient experienced dyspnea
and pleuritic chest pain. Reaccumulated pleural effusions
were noted on a chest radiograph, and an echocardiogram
showed evidence of pericardial effusion. Arterial blood gas
interpreted in conjunction with a corresponding basal
metabolic panel (Table 3) revealed the presence of a non-
anion gap hyperkalemic metabolic acidosis consistent with
type 4 RTA. Analysis of morning serum sample showed a
serum aldosterone level less than 1 ng/dl.
The renal ultrasound obtained showed normal kidney
morphology and no evidence of nephrolithiasis. A renal
biopsy was done, which revealed diffuse global prolifera-
tive and membranous glomerulonephritis. This was con-
sistent with lupus nephritis Renal Pathology Society/
International Society of Nephrology 2003 class IV-G(A)
and V, moderate activity index 9/24, minimal chronicity
index 1/12; minimal tubulointerstitial fibrosis and acute
tubular necrosis (Figure 1).
She was diagnosed with SLE complicated by a general-
ized lupus flare, with a SLEDAI score of 29. Overall dur-
ing this single admission, she demonstrated six of the 11
American College of Rheumatology criteria used in the
diagnosis of SLE.
The patient was treated with a course of hydroxychlor-
oquine and intravenous methylprednisone 1 g daily for
three days. Thereafter she was placed on a prednisone,
mycophenolate mofetil and hydroxychloroquine regimen.
Complete resolution of the renal impairment (Figures 2
and 3) and type 4 RTA (Figure 4) was achieved. She was
discharged after 19 days to follow-up in the Rheumatol-
ogy and Nephrology clinics. Her renal function remained
normal at the one-month follow-up clinic visit.
Discussion
The clinical manifestations of SLE are many and varied,
making it a plausible component of many differential diag-
noses [5]. It is one of several diseases known as “the great
imitators” because it often mimics other diseases. RTA is a
medical condition that involves an accumulation of acid in
the body due to a failure of the kidneys to appropriately
acidify the urine [1].
Table 1 Laboratory investigations on admission to
Jackson Memorial Hospital
Hemoglobin, 6.6 g/dl Na
+, 131 mM/l
Hematocrit, 20.9% K
+, 5.7 mM/l
Platelets, 544 × 10
9/l Cl
-, 105 mM/l
White blood cell
count,
3.5 × 10
9/l
Neutrophils, 80.4% HCO3, 18 mM/l
Lymphocytes,
16.0%
Blood urea nitrogen,
60 mg/dl
Monocytes, 2.1% Creatinine, 1.69 mg/dl
Eosinophils, 0.3%
Table 2 Urinalysis results from day 4 of admission
pH 5 White blood cell count, 16 per high
power field
24-hour urinary protein,
0.81 g/day
Hyaline cast, zero to two per high-
power field
Red blood cell count, 27 per
high-power field
Squamous epithelial cells, one per
high-power field
Table 3 Arterial blood gas and basic metabolic panel
results from day 5 of admission
pH 7.34 Na
+, 145 mM/l
HCO3, 14 mM/l K
+, 5.5 mM/l
CO2, 26 mmHg Cl
-, 120 mM/l
pO2, 96 mmHg HCO3, 19 mM/l
Blood urea nitrogen, 67 mg/dl
Creatinine, 1.09 mg/dl
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renal abnormalities, and 10% to 15% of patients with
lupus nephritis progress to end-stage renal failure [6].
RTA is rarely associated with SLE and, if present, is
more commonly of the type 1 than the type 4 variety
[4]. It likely represents the consequence of significant
tubulointerstitial damage, which should signal the need
for rapid treatment of the underlying lupus nephritis to
avoid future renal insufficiency [7].
In the setting of a hyperkalemic normal anion gap
metabolic acidosis and a urine pH less than 5.5, the
clinician should have a high index of suspicion for the
presence of type 4 RTA. Conversely, a diagnosis of
incomplete type 1 RTA may be entertained in patients
with hyperkalemia and a urine pH which is persistently
greater than 5.5 [8].
The presence of type 4 RTA can be confirmed by calcu-
lating the transtubular potassium concentration gradient
(TTKG) [9]. TTKG is an index of the potassium-secreting
activity of the cells in the distal tubule. In normal indivi-
duals, hyperkalemia is associated with increased aldoster-
one secretion and distal potassium excretion, leading to
a high TTKG level (usually greater than 10). A TTKG
level less than 7 is highly suggestive of hyporeninemic
hypoaldosteronism probably due to tubulointerstitial
damage [10]. Our patient’s calculated TTKG was 5.3
(Table 4).
Other causes of type 4 RTA were ruled out. Our
patient had a normal cortisol level of 14.4 μg/dl, making
adrenal insufficiency unlikely. She divulged no history of
taking non-steroidal anti-inflammatory drugs, potassium-
sparing diuretics, heparin, trimethoprim or angiotensin
receptor blocker use. A history of angiotensin-converting
enzyme inhibitor use was elicited; however, she was
completely non-compliant with the same for the past
three years, making this an unlikely cause.
Figure 1 Photomicrographs of the renal biopsy. (a) Lupus nephritis class IV-G(A) + V (hematoxylin and eosin stain; original magnification,
× 200). (b) Glomerulus showing global endocapillary proliferation, fibrinoid necrosis, neutrophilic infiltration and capillary wall thickening
(hematoxylin and eosin stain; original magnification, × 600). (c) Glomerulus showing mesangial expansion with hypercellularity and occlusion of
peripheral lumina (periodic acid-Schiff stain; original magnification, × 600). (d) Glomerulus showing thickened basement membranes with
numerous spikes and occasional dual contour (methenamine silver stain; original magnification, × 600). (e) Glomerulus showing areas of bright red
fibrinoid necrosis (trichrome stain; original magnification, × 600). (f) Minimal tubulointerstitial fibrosis (trichrome stain; original magnification, × 100).
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Figure 2 Graph showing trend of serum urea during admission.
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Figure 3 Graph showing trend of serum creatinine during admission.
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and SLE in patients with high SLEDAI scores. They
found that the degree of hyperkalemia was correlated
with a high SLEDAI score and that these patients had a
poor outcome of chronic renal insufficiency requiring
hemodialysis at admission or resulting in death. Patients
with type 4 RTA have more extensive tubular damage
stemming from aggressive nephritis associated with
more aggressive systemic manifestations of SLE. Thus,
the presence of type 4 RTA is an indicator of more
aggressive SLE. In our patient, hyperkalemia and a high
SLEDAI score of 29 were noted; however, she did not
do poorly. Her type 4 RTA and significant renal impair-
ment resolved completely after two weeks of appropriate
therapy.
Conclusion
To the best of the authors’ knowledge this is the first
reported case of a patient with SLE who had a high
SLEDAI score and type 4 RTA secondary to lupus
nephritis, yet did not do poorly. This case emphasizes
the fact that early diagnosis and appropriate treatment
can indeed result in the desired positive outcome.
Consent
Written informed consent was obtained from our
patient for publication of this case
report and any accompanying images. A copy of the
written consent is available for review by the Editor-in-
Chief of this journal.
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Figure 4 Graph depicting achievement and maintenance of
normal serum potassium, bicarbonate and urine pH in keeping
with resolution of type 4 renal tubular acidosis.
Table 4 Calculation of transtubular gradient
Urine sodium, 59 mM/l Transtubular gradient
Urine potassium, 38 mM/l Urine K/plasma K
Urine osmolality, 405 mOsm/kg Urine osmolality/plasma osmolality
Plasma potassium, 5.1 mM/l
Plasma osmolality, 288 mOsm/kg Patient’s transtubular gradient = 5.3
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